Comparison of risk scoring systems for critical care patients with upper gastrointestinal bleeding: predicting mortality and length of stay.
gastrointestinal haemorrhage
intensive care unit
length of stay
mortality
Journal
Anaesthesiology intensive therapy
ISSN: 1731-2531
Titre abrégé: Anaesthesiol Intensive Ther
Pays: Poland
ID NLM: 101472620
Informations de publication
Date de publication:
2022
2022
Historique:
pubmed:
9
11
2022
medline:
6
12
2022
entrez:
8
11
2022
Statut:
ppublish
Résumé
Upper gastrointestinal bleeding (UGIB) is a common reason for intensive care admission. While there exist a number of UGIB scoring systems which are used to predict mortality, there are limited studies assessing the discriminative value of these scores in intensive care unit (ICU) patients. The purpose of this study was to analyse five different UGIB scoring systems in predicting ICU mortality and length of stay and compare them to two commonly used ICU mortality scoring systems. We retrospectively identified all patients requiring ICU admission for UGIB to St James's Hospital over an 18-month period. We calculated their AIM65, Glasgow- Blatchford score, pre- and post-Rockall score, ABC, APACHE II and SOFA scores. We used area under the receiver operating characteristic curve (AUROC) to compare the predictive values of these six scoring systems for ICU and hospital mortality as well as ICU length of stay greater than seven days. APACHE II showed excellent discriminative value in predicting mortality in ICU patients (AUROC: 0.87; CI: 0.75-0.99) while the SOFA score showed good discriminative value (AUROC: 0.71; CI: 0.50-0.93). None of the UGIB scoring systems predicted mortality in these patients. All scoring systems showed poor discriminative value in predicting ICU length of stay. We were not able to validate any of these UGIB scoring systems for mortality or length of stay prediction in ICU patients. This study supports the validity of APACHE II as a clinical tool for predicting mortality in ICU patients with UGIB.
Identifiants
pubmed: 36345924
pii: 48067
doi: 10.5114/ait.2022.120741
pmc: PMC10156557
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
310-314Références
Cancer. 1992 Jul 15;70(2):497-503
pubmed: 1617599
J Crit Care. 2017 Oct;41:191-193
pubmed: 28575814
Gastrointest Endosc. 2010 Jun;71(7):1134-40
pubmed: 20598244
Acad Emerg Med. 2015 Jan;22(1):22-30
pubmed: 25556538
Lancet. 2000 Oct 14;356(9238):1318-21
pubmed: 11073021
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Lancet. 2009 Jan 3;373(9657):42-7
pubmed: 19091393
Am J Gastroenterol. 1993 Nov;88(11):1842-9
pubmed: 8237930
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
BMJ. 2012 Jun 13;344:e3412
pubmed: 22695897
J Coll Physicians Surg Pak. 2011 Jan;21(1):4-8
pubmed: 21276376
Gut. 1996 Mar;38(3):316-21
pubmed: 8675081
JAMA Intern Med. 2016 Oct 01;176(10):1492-1499
pubmed: 27532500
Gastrointest Endosc. 2013 Apr;77(4):551-7
pubmed: 23357496
Rev Assoc Med Bras (1992). 2021 Jun;67(5):766-770
pubmed: 34550270
Gastrointest Endosc. 2011 Dec;74(6):1215-24
pubmed: 21907980
Clin Endosc. 2021 Mar;54(2):211-221
pubmed: 32668528
Coll Antropol. 2009 Sep;33(3):831-5
pubmed: 19860111
BMJ. 2017 Jan 4;356:i6432
pubmed: 28053181
Gut. 2021 Apr;70(4):707-716
pubmed: 32723845
JAMA. 2001 Oct 10;286(14):1754-8
pubmed: 11594901
Am J Gastroenterol. 2010 Jun;105(6):1284-91
pubmed: 20051943